scholarly journals The Role of Transcription Enhancer Factors in Cardiovascular Biology

2011 ◽  
Vol 21 (1) ◽  
pp. 1-5 ◽  
Author(s):  
Yi Jin ◽  
Angela F. Messmer-Blust ◽  
Jian Li
2011 ◽  
Vol 9 ◽  
pp. 151-161 ◽  
Author(s):  
T. HOSODA ◽  
M. ROTA ◽  
J. KAJSTURA ◽  
A. LERI ◽  
P. ANVERSA

2015 ◽  
Vol 23 (17) ◽  
pp. 1351-1369 ◽  
Author(s):  
Jingjing Cai ◽  
Juan Wen ◽  
Eileen Bauer ◽  
Hua Zhong ◽  
Hong Yuan ◽  
...  

2019 ◽  
Vol 5 (1) ◽  
pp. 15 ◽  
Author(s):  
Shrey Gandhi ◽  
Frank Ruehle ◽  
Monika Stoll

Cardiovascular diseases (CVDs) affect the heart and the vascular system with a high prevalence and place a huge burden on society as well as the healthcare system. These complex diseases are often the result of multiple genetic and environmental risk factors and pose a great challenge to understanding their etiology and consequences. With the advent of next generation sequencing, many non-coding RNA transcripts, especially long non-coding RNAs (lncRNAs), have been linked to the pathogenesis of CVD. Despite increasing evidence, the proper functional characterization of most of these molecules is still lacking. The exploration of conservation of sequences across related species has been used to functionally annotate protein coding genes. In contrast, the rapid evolutionary turnover and weak sequence conservation of lncRNAs make it difficult to characterize functional homologs for these sequences. Recent studies have tried to explore other dimensions of interspecies conservation to elucidate the functional role of these novel transcripts. In this review, we summarize various methodologies adopted to explore the evolutionary conservation of cardiovascular non-coding RNAs at sequence, secondary structure, syntenic, and expression level.


2016 ◽  
Vol 2016 ◽  
pp. 1-9 ◽  
Author(s):  
Jun Xu ◽  
Ulka Sachdev

Peripheral artery disease (PAD) can result in limb loss within six months of diagnosis in a subset of patients who cannot undergo endovascular or surgical revascularization yet continues to maintain a marginal position in cardiovascular research. While a body of literature continues to grow describing the role of danger signaling and innate immunity in cardiac biology, the role of these pathways in the ischemic myopathy associated with PAD has not been extensively studied. The following report will review the current literature on the role of Toll-like receptor (TLR) signaling in cardiovascular biology as well as in nonischemic myopathy. While attenuation of TLR signaling has not been shown to be clinically useful in the treatment of infectious inflammation, it may show promise in the management of severe arterial insufficiency.


2007 ◽  
Vol 101 (12) ◽  
pp. 1225-1236 ◽  
Author(s):  
Michael V.G. Latronico ◽  
Daniele Catalucci ◽  
Gianluigi Condorelli

Sign in / Sign up

Export Citation Format

Share Document